IVD (In Vitro Diagnostic) devices are medical equipment used for disease diagnosis, monitoring and treatment guidance outside the body (in laboratory settings). These systems analyze samples like blood, urine, and tissues collected from the human body.

Main IVD Product Categories:

1. Clinical Chemistry Analyzers: Blood glucose, lipid panel, electrolytes

2. Hematology Systems: Complete blood count, coagulation tests

3. Molecular Diagnostics: PCR, NGS systems

4. Immunodiagnostic Systems: ELISA, chemiluminescence analyzers

5. Microbiology Devices: Culture systems, antibiotic susceptibility tests

6. POCT (Point-of-Care) Devices: Rapid test kits, portable analyzers

Working Principles:

• Enzymatic reactions (glucose measurement)

• Antigen-antibody interactions (serological tests)

• Nucleic acid amplification (molecular testing)

• Flow cytometry (cell analysis)

Regulations and Standards:

• CE Marking (Europe)

• FDA Approval (USA)

• IVDR (In Vitro Diagnostic Regulation)

Market Dynamics:

• Global market size: Over 100 billion USD

• Growth drivers: Increasing chronic diseases, personalized medicine

• Leading manufacturers: Roche, Abbott, Siemens Healthineers

Emerging Trends:

• AI-powered diagnostics

• Liquid biopsy technologies

• Wearable diagnostic devices

• Microfluidic chip-based testing

Comparison of IVD Market Segments:

Segment	Growth Rate	Key Applications
Molecular Dx	12.5% CAGR	Infectious diseases, oncology
POCT	9.8% CAGR	Diabetes, cardiac markers
Immunoassays	7.2% CAGR	Autoimmune diseases